Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-28
DOI
10.1002/mds.27475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Personalized medicine in Parkinson's disease: Time to be precise
- (2017) Nataliya Titova et al. MOVEMENT DISORDERS
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Andrew J. Lees et al. JAMA Neurology
- Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics
- (2016) José-Francisco Rocha et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A new PAMPA model using an in-house brain lipid extract for screening the blood–brain barrier permeability of drug candidates
- (2016) Joana Bicker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat
- (2015) M J Bonifácio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
- (2015) Thomas Müller DRUGS
- Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
- (2015) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effect of entacapone on colon motility and ion transport in a rat model of Parkinson’s disease
- (2015) Li-Sheng Li WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
- (2014) José-Francisco Rocha et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
- (2014) László E. Kiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Clinical spectrum of levodopa-induced complications
- (2014) Camila Catherine Aquino et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects
- (2013) José Francisco Rocha et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study
- (2013) A. Lees et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor
- (2013) M.J. Bonifácio et al. NEUROPHARMACOLOGY
- Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects
- (2012) Luis Almeida et al. CLINICAL PHARMACOKINETICS
- Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
- (2012) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Late-stage Parkinson disease
- (2012) Miguel Coelho et al. Nature Reviews Neurology
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- 2.241 COMPUTATION OF BINDING AFFINITY OF CATECHOL-O-METHYLTRANSFERASE-OPICAPONE COMPLEXES
- (2011) N. Palma et al. PARKINSONISM & RELATED DISORDERS
- The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
- (2010) Jean-Christophe Corvol et al. ANNALS OF NEUROLOGY
- Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
- (2010) László E. Kiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
- (2009) Angelo Antonini et al. LANCET NEUROLOGY
- Naturalistic evaluation of entacapone in patients with signs and symptoms ofL-dopa wearing-off
- (2008) M. Jog et al. CURRENT MEDICAL RESEARCH AND OPINION
- Treatment of levodopa-induced motor complications
- (2008) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Pharmacokinetics and pharmacodynamics of levodopa
- (2008) John G. Nutt MOVEMENT DISORDERS
- Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search